{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:14:20Z","timestamp":1790435660055,"version":"4.1.0"},"reference-count":29,"publisher":"Impact Journals, LLC","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,5,31]]},"DOI":"10.18632\/oncotarget.8769","type":"journal-article","created":{"date-parts":[[2016,4,17]],"date-time":"2016-04-17T01:35:34Z","timestamp":1460856934000},"page":"32046-32053","source":"Crossref","is-referenced-by-count":28,"title":["Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Olle","family":"Werlenius","sequence":"first","affiliation":[{"name":"Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Aurelius","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hallner","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Akhiani","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Simpanen","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Martner","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ola","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Medicine, S\u00f6dra \u00c4lvsborgs Hospital, Bor\u00e5s, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer","family":"Hellstrand","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik B.","family":"Thor\u00e9n","sequence":"additional","affiliation":[{"name":"TIMM Laboratory, Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2010-07-298356","article-title":"The future of anti-CD20 monoclonal antibodies: are we making progress?","volume":"117","author":"Illidge","year":"2011","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Watier","year":"2002","journal-title":"Blood"},{"key":"3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/2326-6066.CIR-13-0158","article-title":"CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells","volume":"2","author":"Venstrom","year":"2014","journal-title":"Cancer immunology research"},{"key":"4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2009.25.0274","article-title":"Immunoglobulin G Fc receptor FcgammaRIIIa 158 V\/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma","volume":"28","author":"Horning","year":"2010","journal-title":"Journal of clinical oncology"},{"key":"5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000203709","article-title":"Defective natural killer cell activity in B-cell chronic lymphocytic leukaemia is associated with impaired release of natural killer cytotoxic factor(s) but not of tumour necrosis factor-alpha","volume":"96","author":"Eliopoulos","year":"1996","journal-title":"Acta Haematol"},{"key":"6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V63.2.305.305","article-title":"Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells","volume":"63","author":"Zarling","year":"1984","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.156.1.42","article-title":"Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites","volume":"156","author":"Hellstrand","year":"1996","journal-title":"J Immunol"},{"key":"8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2009.03.004","article-title":"The protective role of ROS in autoimmune disease","volume":"30","author":"Holmdahl","year":"2009","journal-title":"Trends Immunol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1089\/ars.2012.4734","article-title":"Hydrogen peroxide as an immunological transmitter regulating autoreactive T cells","volume":"18","author":"Backdahl","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.4049\/jimmunol.153.11.4940","article-title":"Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites","volume":"153","author":"Hermodsson","year":"1994","journal-title":"J Immunol"},{"key":"11","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Gabrilovich","year":"2009","journal-title":"J Immunol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/eji.1830260620","article-title":"Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity","volume":"26","author":"Kiessling","year":"1996","journal-title":"Eur J Immunol"},{"key":"13","article-title":"Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells","author":"Thoren","year":"2012","journal-title":"Haematologica"},{"key":"14","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2011-11-391722","article-title":"Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase\/gp91(phox) expression and the PARP-1\/PAR pathway of apoptosis","volume":"119","author":"Martner","year":"2012","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood.V96.5.1961","article-title":"Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine","volume":"96","author":"Hellstrand","year":"2000","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0512257","article-title":"Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes","volume":"93","author":"Thoren","year":"2013","journal-title":"J Leukoc Biol"},{"key":"17","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.4049\/jimmunol.181.4.2916","article-title":"Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving","volume":"181","author":"Taylor","year":"2008","journal-title":"J Immunol"},{"key":"18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1182\/blood-2014-10-569244","article-title":"Fcgamma-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments","volume":"125","author":"Lindorfer","year":"2015","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1182\/blood-2014-05-574285","article-title":"CD20 antibodies induce production and release of reactive oxygen species by neutrophils","volume":"123","author":"Thoren","year":"2014","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF02782190","article-title":"Alleviating oxidative stress in cancer immunotherapy: a role for histamine?","volume":"17","author":"Naredi","year":"2000","journal-title":"Med Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/bj2900041","article-title":"Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase","volume":"290","author":"England","year":"1993","journal-title":"Biochem J"},{"key":"22","first-page":"1002","article-title":"Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2","volume":"88","author":"Introna","year":"2003","journal-title":"Haematologica"},{"key":"23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10875-011-9624-5","article-title":"Primary B-CLL resistance to NK cell cytotoxicity can be overcomeandby priming NK cells and monoclonal antibody therapy","volume":"32","author":"Olive","year":"2012","journal-title":"Journal of clinical immunology"},{"key":"24","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.4049\/jimmunol.176.12.7301","article-title":"Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes","volume":"176","author":"Hellstrand","year":"2006","journal-title":"J Immunol"},{"key":"25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.179.2.781","article-title":"The CD16-\/CD56bright subset of NK cells is resistant to oxidant-induced cell death","volume":"179","author":"Hellstrand","year":"2007","journal-title":"J Immunol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Kipps","year":"2000","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2141.2011.08902.x","article-title":"Association of an increased frequency of CD14+ HLA-DR lo\/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL)","volume":"156","author":"Dietz","year":"2012","journal-title":"Br J Haematol"},{"key":"28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","article-title":"CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs","volume":"124","author":"Mougiakakos","year":"2014","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/leu.2015.305","article-title":"Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction","volume":"30","author":"Seiffert","year":"2016","journal-title":"Leukemia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T17:38:32Z","timestamp":1692293912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":29,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,5,31]]}},"alternative-id":["8769","27097113"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8769","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}